Sm. Hersch et al., SUBCELLULAR-LOCALIZATION AND MOLECULAR TOPOLOGY OF THE DOPAMINE TRANSPORTER IN THE STRIATUM AND SUBSTANTIA-NIGRA, Journal of comparative neurology, 388(2), 1997, pp. 211-227
Plasma membrane transporters remove neurotransmitters from the extrace
llular space and have been postulated to terminate synaptic activity.
Their specific roles in synaptic and nonsynaptic neurotransmission at
a cellular level, however, remain unclear. We have determined the subc
ellular location of the dopamine transporter (DAT) by immunoperoxidase
and immunogold electron microscopy, using monoclonal antibodies to bo
th the N-terminus and the second extracellular loop. The two DAT epito
pes were found on opposite faces of cellular and intracellular membran
es, providing confirmation of the predicted molecular topology of DAT.
In the striatum, DAT was localized in the plasma membrane of axons an
d terminals. Double immunocytochemistry demonstrated DAT colocalizatio
n with two other markers of nigrostriatal terminals, tyrosine hydroxyl
ase and D2 dopamine receptors. The latter was thus demonstrated to be
an autoreceptor. Labeled striatal terminals formed symmetrical synapse
s with spines, dendrites, and perikarya. DAT was not identified within
any synaptic active zones, however, even using serial section analysi
s. These results suggest that striatal dopamine reuptake may occur out
side of synaptic specializations once dopamine diffuses from the synap
tic cleft. In the substantia nigra, DAT appears to be specifically tra
nsported into dendrites, where it can be found in smooth endoplasmic r
eticulum, plasma membrane, and pre- and postsynaptic active zones. The
se localizations suggest that DAT modulates the intracellular and extr
acellular dopamine levels of nigral dendrites. Within the perikarya of
pars compacta neurons, DAT was localized primarily to rough and smoot
h endoplasmic reticulum, Golgi complex, and multivesicular bodies, ide
ntifying probable sites of synthesis, modification, transport, and deg
radation. (C) 1997 Wiley-Liss, Inc.